Cargando…
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
BACKGROUND: Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in patients with AMI in routine clinical practice. M...
Autores principales: | Betancourt, Blas Y, Marrero-Miragaya, María A, Jiménez-López, Giset, Valenzuela-Silva, Carmen, García-Iglesias, Elizeth, Hernández-Bernal, Francisco, Debesa-García, Francisco, González-López, Tania, Alvarez-Falcón, Leovaldo, López-Saura, Pedro A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1291362/ https://www.ncbi.nlm.nih.gov/pubmed/16262910 http://dx.doi.org/10.1186/1472-6904-5-5 |
Ejemplares similares
-
Granulation Response and Partial Wound Closure Predict Healing in Clinical Trials on Advanced Diabetes Foot Ulcers Treated With Recombinant Human Epidermal Growth Factor
por: Valenzuela-Silva, Carmen M., et al.
Publicado: (2013) -
Biosimilars: the process is the product. The example of recombinant streptokinase
por: Thelwell, C, et al.
Publicado: (2014) -
Recombinant production of Streptococcus equisimilis streptokinase by Streptomyces lividans
por: Pimienta, Elsa, et al.
Publicado: (2007) -
The chronergy of recombinant streptokinase thrombolysis in acute myocardial infarction
por: WANG, ZHONG-MING, et al.
Publicado: (2013) -
Safety of sublingual immunotherapy for asthma with standardized house dust mite vaccines in a tropical setting: Results of a nation-wide pharmacovigilance study
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)